Elevance Health Statistics
Total Valuation
Elevance Health has a market cap or net worth of $61.96 billion. The enterprise value is $85.22 billion.
Important Dates
The next estimated earnings date is Tuesday, April 21, 2026, before market open.
| Earnings Date | Apr 21, 2026 |
| Ex-Dividend Date | Mar 10, 2026 |
Share Statistics
Elevance Health has 220.70 million shares outstanding. The number of shares has decreased by -3.56% in one year.
| Current Share Class | 220.70M |
| Shares Outstanding | 220.70M |
| Shares Change (YoY) | -3.56% |
| Shares Change (QoQ) | -0.85% |
| Owned by Insiders (%) | 0.10% |
| Owned by Institutions (%) | 94.02% |
| Float | 220.23M |
Valuation Ratios
The trailing PE ratio is 11.14 and the forward PE ratio is 10.78. Elevance Health's PEG ratio is 2.17.
| PE Ratio | 11.14 |
| Forward PE | 10.78 |
| PS Ratio | 0.31 |
| Forward PS | 0.31 |
| PB Ratio | 1.41 |
| P/TBV Ratio | 14.28 |
| P/FCF Ratio | 19.52 |
| P/OCF Ratio | 14.44 |
| PEG Ratio | 2.17 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 9.43, with an EV/FCF ratio of 26.85.
| EV / Earnings | 15.05 |
| EV / Sales | 0.43 |
| EV / EBITDA | 9.43 |
| EV / EBIT | 10.27 |
| EV / FCF | 26.85 |
Financial Position
The company has a current ratio of 1.54, with a Debt / Equity ratio of 0.74.
| Current Ratio | 1.54 |
| Quick Ratio | 1.41 |
| Debt / Equity | 0.74 |
| Debt / EBITDA | 3.57 |
| Debt / FCF | 10.32 |
| Interest Coverage | 5.91 |
Financial Efficiency
Return on equity (ROE) is 13.25% and return on invested capital (ROIC) is 9.15%.
| Return on Equity (ROE) | 13.25% |
| Return on Assets (ROA) | 4.35% |
| Return on Invested Capital (ROIC) | 9.15% |
| Return on Capital Employed (ROCE) | 10.31% |
| Weighted Average Cost of Capital (WACC) | 5.71% |
| Revenue Per Employee | $2.05M |
| Profits Per Employee | $58,311 |
| Employee Count | 97,100 |
| Asset Turnover | 1.67 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Elevance Health has paid $1.05 billion in taxes.
| Income Tax | 1.05B |
| Effective Tax Rate | 15.63% |
Stock Price Statistics
The stock price has decreased by -31.44% in the last 52 weeks. The beta is 0.47, so Elevance Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.47 |
| 52-Week Price Change | -31.44% |
| 50-Day Moving Average | 342.76 |
| 200-Day Moving Average | 336.06 |
| Relative Strength Index (RSI) | 28.37 |
| Average Volume (20 Days) | 2,161,342 |
Short Selling Information
The latest short interest is 4.65 million, so 2.11% of the outstanding shares have been sold short.
| Short Interest | 4.65M |
| Short Previous Month | 3.69M |
| Short % of Shares Out | 2.11% |
| Short % of Float | 2.11% |
| Short Ratio (days to cover) | 2.45 |
Income Statement
In the last 12 months, Elevance Health had revenue of $199.13 billion and earned $5.66 billion in profits. Earnings per share was $25.21.
| Revenue | 199.13B |
| Gross Profit | 50.90B |
| Operating Income | 8.30B |
| Pretax Income | 6.71B |
| Net Income | 5.66B |
| EBITDA | 9.04B |
| EBIT | 8.30B |
| Earnings Per Share (EPS) | $25.21 |
Full Income StatementBalance Sheet
The company has $36.12 billion in cash and $32.75 billion in debt, with a net cash position of -$23.26 billion or -$105.39 per share.
| Cash & Cash Equivalents | 36.12B |
| Total Debt | 32.75B |
| Net Cash | -23.26B |
| Net Cash Per Share | -$105.39 |
| Equity (Book Value) | 44.03B |
| Book Value Per Share | 198.81 |
| Working Capital | 21.97B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $4.29 billion and capital expenditures -$1.12 billion, giving a free cash flow of $3.17 billion.
| Operating Cash Flow | 4.29B |
| Capital Expenditures | -1.12B |
| Free Cash Flow | 3.17B |
| FCF Per Share | $14.38 |
Full Cash Flow StatementMargins
Gross margin is 25.56%, with operating and profit margins of 4.17% and 2.84%.
| Gross Margin | 25.56% |
| Operating Margin | 4.17% |
| Pretax Margin | 3.37% |
| Profit Margin | 2.84% |
| EBITDA Margin | 4.54% |
| EBIT Margin | 4.17% |
| FCF Margin | 1.59% |
Dividends & Yields
This stock pays an annual dividend of $6.88, which amounts to a dividend yield of 2.45%.
| Dividend Per Share | $6.88 |
| Dividend Yield | 2.45% |
| Dividend Growth (YoY) | 3.79% |
| Years of Dividend Growth | 15 |
| Payout Ratio | 27.17% |
| Buyback Yield | 3.56% |
| Shareholder Yield | 6.02% |
| Earnings Yield | 9.14% |
| FCF Yield | 5.12% |
Dividend DetailsAnalyst Forecast
The average price target for Elevance Health is $386.59, which is 37.70% higher than the current price. The consensus rating is "Buy".
| Price Target | $386.59 |
| Price Target Difference | 37.70% |
| Analyst Consensus | Buy |
| Analyst Count | 18 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | 12.53% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on June 1, 2005. It was a forward split with a ratio of 2:1.
| Last Split Date | Jun 1, 2005 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |
